The Discussion of Management Review in OMCL Through SWOT Analysis

YU Xin

Chinese Pharmaceutical Journal ›› 2020, Vol. 55 ›› Issue (19) : 1644-1648.

PDF(3241 KB)
PDF(3241 KB)
Chinese Pharmaceutical Journal ›› 2020, Vol. 55 ›› Issue (19) : 1644-1648. DOI: 10.11669/cpj.2020.19.016

The Discussion of Management Review in OMCL Through SWOT Analysis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 55(19): 1644-1648 https://doi.org/10.11669/cpj.2020.19.016

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(3241 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉